Jean-Pierre Bizzari - 23 Aug 2023 Form 3 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
Director
Signature
/s/ John Hamill, as Attorney-in-Fact
Issuer symbol
APRE
Transactions as of
23 Aug 2023
Net transactions value
$0
Form type
3
Filing time
24 Aug 2023, 21:45:30 UTC
Previous filing
09 May 2023
Next filing
02 Jan 2024

No securities are beneficially owned.

Remarks:

Exhibit 24.1 Power of Attorney